Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sven-Christian Sensken"'
Autor:
Daniel Weiss, Georg Ebersbach, Jens Carsten Möller, Johannes Schwarz, Carolin Arlt, Björn Fritz, Sven-Christian Sensken, Karla Eggert
Publikováno v:
Parkinsonism & Related Disorders. 103:85-91
Advanced Parkinson's disease is characterized by motor and non-motor fluctuations to oral dopamine replacement therapy. The BALANCE study evaluated the clinical practice in Germany and Switzerland, when patients eligible for levodopa/carbidopa intest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bf9c9d474a71664362392a21ea01813
https://doi.org/10.1016/j.parkreldis.2022.08.018
https://doi.org/10.1016/j.parkreldis.2022.08.018
Autor:
Sven Christian Sensken, Paul Lingor, Juan Carlos Parra, Alessandro Stefani, Ashley Yegin, Rejko Krüger, Triantafyllos Doskas, Erik H. Danielsen, Koray Onuk, Oriol De Fabregues, Johanna M.L. Henselmans, Angelo Antonini
Publikováno v:
Advances in Therapy
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Krueger, R, Lingor, P, Doskas, T, Henselmans, J M L, Danielsen, E H, de Fabregues, O, Stefani, A, Sensken, S-C, Parra, J C, Onuk, K, Yegin, A & Antonini, A 2017, ' An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients ', Advances in Therapy, vol. 34, no. 7, pp. 1741-1752 . https://doi.org/10.1007/s12325-017-0571-2
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Krueger, R, Lingor, P, Doskas, T, Henselmans, J M L, Danielsen, E H, de Fabregues, O, Stefani, A, Sensken, S-C, Parra, J C, Onuk, K, Yegin, A & Antonini, A 2017, ' An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients ', Advances in Therapy, vol. 34, no. 7, pp. 1741-1752 . https://doi.org/10.1007/s12325-017-0571-2
Introduction Continuous delivery of levodopa–carbidopa intestinal gel (LCIG) by percutaneous endoscopic gastrojejunostomy (PEG-J) in advanced Parkinson’s disease (PD) patients reduces variability in plasma levels, providing better control of moto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05b8168cacd1cb54a26fbfe27be3aed7
https://pubmed.ncbi.nlm.nih.gov/28631218
https://pubmed.ncbi.nlm.nih.gov/28631218
Autor:
Richard Dodel, Jens-Peter Reese, Oliver Riedel, Sven-Christian Sensken, Monika Balzer-Geldsetzer, Hans-Ulrich Wittchen, Dirk Enders, Björn Wolff
Publikováno v:
European neurology. 78(3-4)
Background: Epidemiological data on the prevalence of Parkinson's disease (PD) in Germany are limited. The aims of this study were to estimate the age- and gender-specific prevalence of PD in Germany as well as the severity and illness duration. Summ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52b03611de51e6443844c5a07ecaab8f
https://pubmed.ncbi.nlm.nih.gov/28746937
https://pubmed.ncbi.nlm.nih.gov/28746937
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 328:963-969
The immunomodulator fingolimod (FTY720) induces lymphopenia by inhibiting lymphocyte egress from thymus and secondary lymphoid organs (SLOs). It is phosphorylated mainly by sphingosine kinase (SK) 2 in vivo. FTY720-phosphate (FTY-P) activated and rap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a99fa8caba8aa03b02be1e11e56e1c
https://doi.org/10.1124/jpet.108.148163
https://doi.org/10.1124/jpet.108.148163
Autor:
Manju Nagarajan, Markus H. Gräler, Sven-Christian Sensken, Ulrike Peest, Constantin Bode, Oliver Pabst
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 184(8)
Sphingosine kinases (SKs) 1 and 2 produce high concentrations of sphingosine 1-phosphate (S1P) in blood and lymph. In contrast, S1P concentrations in lymphoid tissues are kept low by the S1P-degrading activity of the S1P-lyase. These differences in S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a9dca13ea546448fe5bf342f8a098fb
https://pubmed.ncbi.nlm.nih.gov/20220090
https://pubmed.ncbi.nlm.nih.gov/20220090
Publikováno v:
The Journal of biological chemistry. 285(9)
The sphingosine 1-phosphate receptor type 1 (S1P(1)) is important for the maintenance of lymphocyte circulation. S1P(1) receptor surface expression on lymphocytes is critical for their egress from thymus and lymph nodes. Premature activation-induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9151cb1ed508b1e618057e3ca40d7442
https://pubmed.ncbi.nlm.nih.gov/20032465
https://pubmed.ncbi.nlm.nih.gov/20032465
Autor:
Petra Hänel, Paul Andréani, Sven-Christian Sensken, Paul P. Van Veldhoven, Markus H. Gräler, Ulrike Peest
Publikováno v:
Journal of cellular biochemistry. 104(3)
Sphingosine 1-phosphate (S1P) is the natural ligand for a specific family of G protein-coupled receptors (-Rs). The type 1 S1P-R (S1P1) is important for lymphocyte egress, and blood-borne S1P as the natural ligand for S1P1 is involved in the maintena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a8cc62a70b36c7cbae50d70b848a08c
https://pubmed.ncbi.nlm.nih.gov/18172856
https://pubmed.ncbi.nlm.nih.gov/18172856
Autor:
Sven-Christian Sensken, Bodo Levkau, Claudia Stäubert, Markus H. Gräler, Petra Keul, Torsten Schöneberg
Publikováno v:
Cellular signalling. 20(6)
The immune modulator FTY720 is phosphorylated in vivo to FTY720 phosphate (FTY-P), which activates four sphingosine 1-phosphate (S1P) receptors including S1P(3). Upon activation with S1P, S1P(3) couples to G(i)- and G(q)-protein-dependent signalling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6334c9bb1d2d7b7a5c5d265db7e64cad
https://pubmed.ncbi.nlm.nih.gov/18313900
https://pubmed.ncbi.nlm.nih.gov/18313900